|
|
|
题名
|
作者
|
年代
|
出处
|
被引量
|
| 1 | Adeno-associated virus-mediated heme oxygenase-1 gene transfer suppresses the progression of micronodular cirrhosis in rats显示文摘瞄准:测试假设这项活动的那改进他我有与周期性的肝损伤联系的纤维发生的过程的氧合酶罐头 interfere,我们调查了在表示上的治疗学的潜力他我在 CCl (4 ) 的 oxygense-1 劝诱了微榴状的肝硬化模型。方法:带老鼠 HO-1 或 GFP 基因的 Recombinant 联系 adeno 的病毒被产生。1x 10 (12 )联系 adeno 的病毒的 vg 在肝的正式就职的时候通过门注射被管理纤维变性。结果:有由 rAAV/HO-1 的 HO-1 的在表示上的老鼠肝显著地增加了的调节以一种稳定的方式的 HO 酶的活动。微榴状的肝硬化的开发显著地作为与控制相比在 rAAV/HO-1-transduced 动物被禁止。门静脉高血压显著地作为与控制相比在 rAAV/HO-1-transduced 动物被减少,而在收缩血压没有重要变化。这发现伴有激活的改进的肝生物化学,更少的渗透的巨噬细胞和更少在 rAAV/HO-1-transduced 肝的肝的星形细胞(HSC ) 。结论:改进惊讶在肝的活动压制肝硬化的发展。 | Tung-Yu Tsui Chi-Keung Lau Jian Ma Gabriel Glockzin Aiman Obed Hans J Schlitt Sheung-Tat Fan | 2006 | World Journal of Gastroenterology2006，12，13： | 9 |
| 2 | Current Status and Future Directions in Gastric Cancer with Peritoneal Dissemination显示文摘 | Gabriel Glockzin Pompiliu Piso | 2012 | Surgical Oncology Clinics of North America2012，，4： | 1 |
| 3 | Surgical treatment of sub- sternal goiter: an analysis of 59 patients显示文摘 | Agha A Glockzin G Ghali N | 2008 | Surg Today2008，38，6： | 1 |
| 4 | Completion thyroidectomy : effect of timing on clinical complications and oncologic outcome in patients with differentiated thyroid cancer显示文摘 | Glockzin G Homung M Kienle K | 2012 | World J Surg2012，36，5： | 1 |
| 5 | Completion thy-roidectomy :effect of timing on clinical complications andoncologic outcome in patients with differentiated thyroidcancer显示文摘 | Glockzin G Homung M Kienle K | 2012 | World J Surg2012，36，5： | 1 |
| 6 | Surgical treatment of substernal goiter:an analysis of 59 patients显示文摘 | Agha A Glockzin G Ghali N | 2008 | Surg Today2008，38，6： | 1 |
| 7 | Quality of life after cytoreductive surgery and hyperthermic intraperitoneal chemotherapy for peritoneal surface malignancies 显示文摘 | Piso P Glockzin G von Breitenbuch P | 2009 | J Surg Oncol2009，100，4： | 1 |
| 8 | Results of cytoreductive surgery and hyperthermie intraperitoneal chemotherapy for peritoneal careinomatosis from colorectal cancer显示文摘 | Glockzin G Ghali N Lang SA | 2009 | J Surg Oncol2009，100，4： | 1 |
| 9 | Current status and future directions in gastric cancer with peritoneal dissemination显示文摘 | Glockzin G Piso P | 2012 | Surg Oncol Clin N Am2012，21，4： | 1 |
| 10 | Peritoneal carcinomatosis: patients selection, perioperative complications and quality of life related to cytoreductive surgery and hyperthermic intraperitoneal chemotherapy显示文摘 | Glockzin G Schlitt HJ Piso P | 2009 | World J Surg Oncol2009，8，7： | 1 |
| 11 | Treatment‐related morbidity and toxicity of CRS and oxaliplatin‐based HIPEC compared to a mitomycin and doxorubicin‐based HIPEC protocol in patients with peritoneal carcinomatosis: A matched‐pair analysis显示文摘 | Gabriel Glockzin Philipp von Breitenbuch Hans J. Schlitt Pompiliu Piso | 2012 | J. Surg. Oncol2012，，： | 1 |
| 12 | Characterization of the recombinant adenovirus vector AdYB-1:implications for theolytic vector development显示文摘 | Glockzin G Mantwill K Jurechott K | 2006 | Virology2006，80，8： | 1 |
| 13 | Completion thy- roidectomy effect of timing on clinical complcations and onclologic outcome in patients with differentiated thyroid cancer显示文摘 | Glockzin GH ornung M Kienle K | 2012 | World J Surg2012，36，5： | 1 |
| 14 | Completion thyroidectomy: effect of timing on clinical complications and oneologie outcome in patients with differentiated thyroid cancer 显示文摘 | Glockzin G Homung M Kienle K | 2012 | World J Surg2012，36，5： | 1 |
| 15 | Surgical treatment of substeaaal goiter: an analysis of 59 patients 显示文摘 | Agha A Glockzin G Ghali N | 2008 | Surg Today2008，38，6： | 1 |
| 16 | Current status and future directions in gastric cancer with peritoneal dissemination显示文摘 | Glockzin G Piso P | 2012 | Surg Oncol Clin N Am2012，21，4： | 1 |
| 17 | Surgical treatment of substernal goiter:an analysis of59patients显示文摘 | Agha A Glockzin G Ghali N | 2008 | Surg Today2008，38，6： | 1 |
| 18 | Current status and future directions in gastric cancer with peritoneal dissemination 显示文摘 | Glockzin G Piso P | 2012 | Surg Oncol Clin N Am2012，21，4： | 1 |
| 19 | Therapeutic options for peritoneal metastasis arising from colorectal cancer显示文摘Peritoneal metastasis is a common sign of advanced tumor stage, tumor progression or tumor recurrence in patients with colorectal cancer. Due to the improvement of systemic chemotherapy, the development of targeted therapy and the introduction of additive treatment options such as cytoreductive surgery(CRS) and hyperthermic intraperitoneal chemotherapy(HIPEC), the therapeutic approach to peritoneal metastatic colorectal cancer(pm CRC) has changed over recent decades, and patient survival has improved. Moreover, in contrast to palliative systemic chemotherapy or best supportive care, the inclusion of CRS and HIPEC as inherent components of a multidisciplinary treatment regimen provides a therapeutic approach with curative intent. Although CRS and HIPEC are increasingly accepted as the standard of care for selected patients and have become part of numerous national and international guidelines, the individual role, optimal timing and ideal sequence of the different systemic, local and surgical treatment options remains a matter of debate. Ongoing and future randomized controlled clinical trials may help clarify the impact of the different components, allow for further improvement of patient selection and support the standar-dization of oncologic treatment regimens for pm CRC. The addition of further therapeutic options such as neo-adjuvant intraperitoneal chemotherapy or pressurized intraperitoneal aerosol chemotherapy, should be investig-ated to optimize therapeutic regimens and further improve the oncological outcome. | Gabriel Glockzin Hans J Schlitt Pompiliu Piso | 2016 | World Journal of Gastrointestinal Pharmacology and Therapeutics2016，7，3： | 1 |
| 20 | Surgical treatment of substernal goiter: an analysis of 59 patients显示文摘 | Agha A Glockzin G Ghali N | 2008 | Surg Today2008，38，6： | 1 |
您所在的机构暂未开通此部分的功能，请联系管理员